-transparent.png){kind=logo}
We investigated the cause of membranous glomerulonephritis (MGN) in 24 patients with rheumatoid arthritis (RA). The class or stage of RA was diagnosed using the criteria of the American Rheumatism Association, and MGN was diagnosed using renal biopsy. Renal biopsy and laboratory findings, including serologic analysis, were evaluated. Eighteen patients had previously received one of the following antirheumatic agents: bucillamine (n = 13), D-penicillamine (n = 3), or gold (n = 2). The renal lesions of all 24 patients resembled lesions seen with idiopathic MGN on examination by light microscopy, electron microscopy, and immunofluorescence. We concluded that patients with RA are predisposed to develop MGN, whether or not they receive antirheumatic agents.
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
March 1992,
Nihon Jinzo Gakkai shi,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
June 1991,
Nihon Jinzo Gakkai shi,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
June 1987,
Annals of the rheumatic diseases,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
September 1985,
Clinical nephrology,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
January 1980,
Nephrologie,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
January 1979,
The Journal of rheumatology,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
June 1984,
The Journal of rheumatology,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
November 2007,
Clinical nephrology,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
April 1978,
Southern medical journal,
A Yoshida, and
K Morozumi, and
A Takeda, and
K Koyama, and
T Oikawa
January 1989,
Revmatologiia (Moscow, Russia),
